Enhancer of zeste homolog 2: A potential target for tumor therapy

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 4, 2011, Pages 474-477

  Xiao, Yongtao ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cancer therapy; Enhancer of zeste homolog 2; H3K27; Methylation; Phosphorylation

Indexed keywords

TRANSCRIPTION FACTOR EZH2;

ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CHROMOSOME 21Q; CHROMOSOME 7Q; CYTOPLASM; EXON; GENE SILENCING; HUMAN; METHYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE;

EID: 79952105934     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.01.005     Document Type: Short Survey

References (29)

1. R.J. Bryant, S.J. Winder, S.S. Cross, F.C. Hamdy, and V.T. Cunliffe The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells Prostate 68 3 2008 255 263 (Pubitemid 351273054)
2. S. Burdach, S. Plehm, R. Unland, U. Dirksen, A. Borkhardt, and M.S. Staege Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2 Cell Cycle 8 13 2009 1991 1996
3. Q. Cao, J. Yu, S.M. Dhanasekaran, J.H. Kim, R.S. Mani, and S.A. Tomlins Repression of E-cadherin by the Polycomb group protein EZH2 in cancer Oncogene 27 58 2008 7274 7284
4. R. Cao, L. Wang, H. Wang, L. Xia, H. Erdjument-Bromage, and P. Tempst Role of histone H3 lysine 27 methylation in Polycomb-group silencing Science 298 5595 2002 1039 1043 (Pubitemid 35247314)
5. C. Cardoso, C. Mignon, G. Hetet, B. Grandchamps, M. Fontes, and L. Colleaux The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders Eur J Hum Genet 8 3 2000 174 180 (Pubitemid 30189860)
6. C. Cardoso, S. Timsit, L. Villard, M. Khrestchatisky, M. Fontes, and L. Colleaux Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein Hum Mol Genet 7 4 1998 679 684 (Pubitemid 28152267)
7. T.L. Cha, B.P. Zhou, W. Xia, Y. Wu, C.C. Yang, and C.T. Chen Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3 Science 310 5746 2005 306 310 (Pubitemid 41457195)
8. H. Chen, C. Rossier, and S.E. Antonarakis Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2 Genomics 38 1 1996 30 37 (Pubitemid 26423910)
9. Y. Chen, M.C. Lin, H. Yao, H. Wang, A.Q. Zhang, and J. Yu Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin Hepatology 46 1 2007 200 208 (Pubitemid 47171937)
10. S. Chen, L.R. Bohrer, A.N. Rai, Y. Pan, L. Gan, and X. Zhou Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2 Nat Cell Biol 12 11 2010 1108 1114
11. G. De Haan, and A. Gerrits Epigenetic control of hematopoietic stem cell aging the case of EZH2 Ann N Y Acad Sci 1106 2007 233 239 (Pubitemid 47443044)
12. K. Dohner, J. Brown, U. Hehmann, C. Hetzel, J. Stewart, and G. Lowther Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders Blood 92 11 1998 4031 4035 (Pubitemid 28544315)
13. Z. Han, X. Xing, M. Hu, Y. Zhang, P. Liu, and J. Chai Structural basis of EZH2 recognition by EED Structure 15 10 2007 1306 1315 (Pubitemid 47539160)
14. C.G. Kleer, Q. Cao, S. Varambally, R. Shen, I. Ota, and S.A. Tomlins EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc Natl Acad Sci U S A 100 20 2003 11606 11611 (Pubitemid 37205983)
15. Y. Komohara, M. Harada, Y. Arima, S. Suekane, M. Noguchi, and A. Yamada Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma Int J Oncol 29 6 2006 1555 1560
16. M. Malumbres, and M. Barbacid Cell cycle CDKs and cancer: a changing paradigm Nat Rev Cancer 9 3 2009 153 166
17. R. Margueron, G. Li, K. Sarma, A. Blais, J. Zavadil, and C.L. Woodcock EZH1 and EZH2 maintain repressive chromatin through different mechanisms Mol Cell 32 4 2008 503 518
18. E. Mattioli, P. Vogiatzi, A. Sun, G. Abbadessa, G. Angeloni, and D. D'Ugo Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer J Cell Physiol 210 1 2007 183 191 (Pubitemid 44904714)
19. R.D. Morin, N.A. Johnson, T.M. Severson, A.J. Mungall, J. An, and R. Goya Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin Nat Genet 42 2 2010 181 185
20. K. Plath, J. Fang, S.K. Mlynarczyk-Evans, R. Cao, K.A. Worringer, and H. Wang Role of histone H3 lysine 27 methylation in X inactivation Science 300 5616 2003 131 135 (Pubitemid 36423045)
21. J.D. Raman, N.P. Mongan, S.K. Tickoo, S.A. Boorjian, D.S. Scherr, and L.J. Gudas Increased expression of the Polycomb group gene, EZH2, in transitional cell carcinoma of the bladder Clin Cancer Res 11 24 Pt 1 2005 8570 8576 (Pubitemid 43005902)
22. D.R. Rhodes, M.G. Sanda, A.P. Otte, A.M. Chinnaiyan, and M.A. Rubin Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer J Natl Cancer Inst 95 9 2003 661 668 (Pubitemid 36603722)
23. J.A. Simon, and R.E. Kingston Mechanisms of Polycomb gene silencing: knowns and unknowns Nat Rev Mol Cell Biol 10 10 2009 697 708
24. A. Sparmann, and M. van Lohuizen Polycomb silencers control cell fate, development and cancer Nat Rev Cancer 6 11 2006 846 856 (Pubitemid 44629896)
25. I.H. Su, A. Basavaraj, A.N. Krutchinsky, O. Hobert, A. Ullrich, and B.T. Chait EZH2 controls B cell development through histone H3 methylation and Igh rearrangement Nat Immunol 4 2 2003 124 131 (Pubitemid 36193013)
26. T. Sudo, T. Utsunomiya, K. Mimori, H. Nagahara, K. Ogawa, and H. Inoue Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma Br J Cancer 92 9 2005 1754 1758 (Pubitemid 40756488)
27. S. Varambally, Q. Cao, R.S. Mani, S. Shankar, X. Wang, and B. Ateeq Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 5908 2008 1695 1699
28. S. Varambally, S.M. Dhanasekaran, M. Zhou, T.R. Barrette, C. Kumar-Sinha, and M.G. Sanda The Polycomb group protein EZH2 is involved in progression of prostate cancer Nature 419 6907 2002 624 629
29. E. Vire, C. Brenner, R. Deplus, L. Blanchon, M. Fraga, and C. Didelot The Polycomb group protein EZH2 directly controls DNA methylation Nature 439 7078 2006 871 874 (Pubitemid 43255707)